Inflammatory myofibroblastic tumour (IMT) is an uncommon mass lesion composed of myofibroblasts and mixed inflammatory infiltrate that rarely undergoes malignant transformation. Although IMT was originally reported in the lung, it is now recognised that it can occur in a variety of organs. Hepatic localisation of IMT is less frequent. Here we report two cases of IMT in the liver. They underwent hepatic resections with the diagnosis of FNH and Klatskin tumour. The pathological diagnosis of the tumour was IMT. We conclude that in the management of IMT in the liver, surgical excision is the primary choice, in order to obtain a definitive diagnosis as well as to relieve symptoms, and strict follow-up after surgery is required for the timely detection of recurrence.

Download full-text PDF

Source
http://dx.doi.org/10.1080/00015458.2010.11680573DOI Listing

Publication Analysis

Top Keywords

tumour imt
12
imt liver
12
report cases
8
imt
7
inflammatory myofibroblasts
4
tumour
4
myofibroblasts tumour
4
liver report
4
cases inflammatory
4
inflammatory myofibroblastic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!